STERIS plc (STE)
Pre-market:
| Previous close | 202.80 |
| Open | 202.11 |
| Bid | 80.62 x 1300 |
| Ask | 322.46 x 800 |
| Day's range | 200.41 - 202.21 |
| 52-week range | 185.22 - 254.00 |
| Volume | |
| Avg. volume | 491,703 |
| Market cap | 19.915B |
| Beta (5Y monthly) | 0.79 |
| PE ratio (TTM) | 35.48 |
| EPS (TTM) | 5.68 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | 2.08 (1.03%) |
| Ex-dividend date | 22 Feb 2024 |
| 1y target est | 239.86 |
GlobeNewswireSTERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024
DUBLIN, IRELAND, April 24, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 fourth quarter and full year financial results at 9:00 a.m. ET on May 9, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing fin
ZacksShould You Buy STERIS (STE) Stock Ahead of Q4 Earnings?
STERIS (STE) is expected to have witnessed the normalization of the Healthcare backlog, as the company is currently able to ship at a faster pace than the receipt of new orders.
Simply Wall St.Is The Market Rewarding STERIS plc (NYSE:STE) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
STERIS (NYSE:STE) has had a rough month with its share price down 13%. We, however decided to study the company's...
